{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:52:56Z","timestamp":1790992376533,"version":"4.1.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Agent\u00fara na Podporu V\u00fdskumu a V\u00fdvoja","doi-asserted-by":"publisher","award":["APVV-21-0108"],"award-info":[{"award-number":["APVV-21-0108"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60085-w","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:55:54Z","timestamp":1783011354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computer-assisted design of arylethylbenzamides as predicted nanomolar inhibitors of papain-like cysteine protease of SARS-CoV-2"],"prefix":"10.1038","volume":"16","author":[{"given":"Lukas","family":"Kerti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Frecer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"60085_CR1","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1021\/acs.jmedchem.1c01307","volume":"65","author":"Z Shen","year":"2022","unstructured":"Shen, Z. et al. Design of SARS-CoV-2 PLpro inhibitors for COVID-19 antiviral therapy leveraging binding cooperativity. J. Med. Chem. 65, 2940\u20132955 (2022).","journal-title":"J. Med. Chem."},{"key":"60085_CR2","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1126\/science.adm9724","volume":"383","author":"B Tan","year":"2024","unstructured":"Tan, B. et al. Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model. Science 383, 1434\u20131440 (2024).","journal-title":"Science"},{"key":"60085_CR3","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/s41467-023-37254-w","volume":"14","author":"BC Sanders","year":"2023","unstructured":"Sanders, B. C. et al. Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2. Nat. Commun. 14, 1733 (2023).","journal-title":"Nat. Commun."},{"key":"60085_CR4","doi-asserted-by":"publisher","first-page":"7561","DOI":"10.1021\/acs.jmedchem.2c00303","volume":"65","author":"H Tan","year":"2022","unstructured":"Tan, H., Hu, Y., Jadhav, P., Tan, B. & Wang, J. Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease. J. Med. Chem. 65, 7561\u20137580 (2022).","journal-title":"J. Med. Chem."},{"key":"60085_CR5","doi-asserted-by":"publisher","first-page":"16119","DOI":"10.1073\/pnas.0805240105","volume":"105","author":"K Ratia","year":"2008","unstructured":"Ratia, K. et al. A noncovalent class of papain-like protease\/deubiquitinase inhibitors blocks SARS virus replication. Proc. Natl. Acad. Sci. 105, 16119\u201316124 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"60085_CR6","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1021\/jm900611t","volume":"52","author":"AK Ghosh","year":"2009","unstructured":"Ghosh, A. K. et al. Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome\u2013coronavirus papain-like protease. J. Med. Chem. 52, 5228\u20135240 (2009).","journal-title":"J. Med. Chem."},{"key":"60085_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd4596","volume":"6","author":"W Rut","year":"2020","unstructured":"Rut, W. et al. Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti\u2013COVID-19 drug design. Sci. Adv. 6, eabd4596 (2020).","journal-title":"Sci. Adv."},{"key":"60085_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202200327","volume":"23","author":"S Ullrich","year":"2022","unstructured":"Ullrich, S. & Nitsche, C. SARS-CoV-2 papain-like protease: Structure, function and inhibition. ChemBioChem 23, e202200327 (2022).","journal-title":"ChemBioChem"},{"key":"60085_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010667","volume":"18","author":"AP Perlinska","year":"2022","unstructured":"Perlinska, A. P. et al. Amino acid variants of SARS-CoV-2 papain-like protease have impact on drug binding. PLoS Comput. Biol. 18, e1010667 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"60085_CR10","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s41590-021-01035-8","volume":"22","author":"D Munnur","year":"2021","unstructured":"Munnur, D. et al. Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection. Nat. Immunol. 22, 1416\u20131427 (2021).","journal-title":"Nat. Immunol."},{"key":"60085_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","volume":"587","author":"D Shin","year":"2020","unstructured":"Shin, D. et al. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature 587, 657\u2013662 (2020).","journal-title":"Nature"},{"key":"60085_CR12","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1042\/BST20220839","volume":"50","author":"D Munnur","year":"2022","unstructured":"Munnur, D., Banducci-Karp, A. & Sanyal, S. ISG15 driven cellular responses to virus infection. Biochem. Soc. Trans. 50, 1837\u20131846 (2022).","journal-title":"Biochem. Soc. Trans."},{"key":"60085_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2024.117909","volume":"113","author":"L Kerti","year":"2024","unstructured":"Kerti, L. & Frecer, V. Design of inhibitors of SARS-CoV-2 papain-like protease deriving from GRL0617: Structure\u2013activity relationships. Bioorg. Med. Chem. 113, 117909 (2024).","journal-title":"Bioorg. Med. Chem."},{"key":"60085_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.876212","volume":"10","author":"DJ Calleja","year":"2022","unstructured":"Calleja, D. J., Lessene, G. & Komander, D. Inhibitors of SARS-CoV-2 PLpro. Front. Chem. 10, 876212 (2022).","journal-title":"Front. Chem."},{"key":"60085_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.antiviral.2017.11.001","volume":"149","author":"J Lei","year":"2018","unstructured":"Lei, J., Kusov, Y. & Hilgenfeld, R. Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. Antivir. Res. 149, 58\u201374 (2018).","journal-title":"Antivir. Res."},{"issue":"1","key":"60085_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41467-021-21060-3","volume":"12","author":"J Osipiuk","year":"2021","unstructured":"Osipiuk, J. et al. Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. Nat. Commun. 12743. (2021).","journal-title":"Nat. Commun."},{"key":"60085_CR17","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1021\/jm401712t","volume":"57","author":"YM B\u00e1ez-Santos","year":"2014","unstructured":"B\u00e1ez-Santos, Y. M. et al. X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases. J. Med. Chem. 57, 2393\u20132412 (2014).","journal-title":"J. Med. Chem."},{"key":"60085_CR18","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1021\/acsinfecdis.0c00168","volume":"6","author":"BT Freitas","year":"2020","unstructured":"Freitas, B. T. et al. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease. ACS Infect. Dis. 6, 2099\u20132109 (2020).","journal-title":"ACS Infect. Dis."},{"key":"60085_CR19","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1021\/acscentsci.1c00519","volume":"7","author":"C Ma","year":"2021","unstructured":"Ma, C. et al. Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay. ACS Cent. Sci. 7, 1245\u20131260 (2021).","journal-title":"ACS Cent. Sci."},{"key":"60085_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20718-8","volume":"12","author":"Z Fu","year":"2021","unstructured":"Fu, Z. et al. The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery. Nat. Commun. 12, 488 (2021).","journal-title":"Nat. Commun."},{"key":"60085_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.apsb.2020.08.014","volume":"11","author":"X Gao","year":"2021","unstructured":"Gao, X. et al. Crystal structure of SARS-CoV-2 papain-like protease. Acta Pharm. Sinica B. 11, 237\u2013245 (2021).","journal-title":"Acta Pharm. Sinica B"},{"key":"60085_CR22","doi-asserted-by":"publisher","unstructured":"Garnsey, M. R. et al. Discovery of SARS-CoV-2 papain-like protease (PLpro) inhibitors with efficacy in a murine infection model. 01.26.577395 Preprint at (2024). https:\/\/doi.org\/10.1101\/2024.01.26.577395 (2024).","DOI":"10.1101\/2024.01.26.577395"},{"issue":"1","key":"60085_CR23","doi-asserted-by":"publisher","first-page":"10169","DOI":"10.1038\/s41467-024-54462-0","volume":"15","author":"Y Lu","year":"2024","unstructured":"Lu, Y. et al. Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19. Nat. Commun. 1510169. (2024).","journal-title":"Nat. Commun."},{"key":"60085_CR24","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/cmdc.202000223","volume":"15","author":"AK Ghosh","year":"2020","unstructured":"Ghosh, A. K., Brindisi, M., Shahabi, D., Chapman, M. E. & Mesecar, A. D. Drug development and medicinal chemistry efforts toward SARS-coronavirus and COVID-19 therapeutics. ChemMedChem 15, 907\u2013932 (2020).","journal-title":"ChemMedChem"},{"key":"60085_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013468","volume":"21","author":"X Wu","year":"2025","unstructured":"Wu, X. et al. Divergent resistance pathways amongst SARS-CoV-2 PLpro inhibitors highlight the need for scaffold diversity. PLoS Pathog. 21, e1013468 (2025).","journal-title":"PLoS Pathog."},{"key":"60085_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.04.011","author":"M Zheng","year":"2024","unstructured":"Zheng, M. et al. Discovery and characterization of novel potent non-covalent small molecule inhibitors targeting papain-like protease from SARS-CoV-2. Acta Pharm. Sinica B. https:\/\/doi.org\/10.1016\/j.apsb.2024.04.011 (2024).\u00a0","journal-title":"Acta Pharm. Sinica B"},{"key":"60085_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2024.130034","volume":"116","author":"CC Rouch","year":"2025","unstructured":"Rouch, C. C. et al. Synthesis and structure-activity relationship of covalent inhibitors of SARS-CoV-2 papain-like protease with antiviral potency. Bioorg. Med. Chem. Lett. 116, 130034 (2025).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"60085_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. The protein data bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"60085_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","volume":"21","author":"JC Shelley","year":"2007","unstructured":"Shelley, J. C. et al. Epik: a software program for pKaprediction and protonation state generation for drug-like molecules. J. Comput. Aided Mol. Des. 21, 681\u2013691 (2007).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"60085_CR30","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","volume":"19","author":"RC Johnston","year":"2023","unstructured":"Johnston, R. C. et al. Epik: pKa and Protonation State Prediction through Machine Learning. J. Chem. Theory Comput. 19, 2380\u20132388 (2023).","journal-title":"J. Chem. Theory Comput."},{"key":"60085_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221\u2013234 (2013).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"60085_CR32","unstructured":"Protein Preparation Wizard. Epik, Impact modules and Prime, Small-Molecule Discovery Suite, Release 2025-3, Schr\u00f6dinger (LLC, 2025)."},{"key":"60085_CR33","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu, C. et al. OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space. J. Chem. Theory Comput. 17, 4291\u20134300 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"60085_CR34","unstructured":"Fields, F. & Suite, S. M. D. Release 2025-3, Schr\u00f6dinger (LLC, 2025)."},{"key":"60085_CR35","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1021\/ja00172a038","volume":"112","author":"WC Still","year":"1990","unstructured":"Still, W. C., Tempczyk, A., Hawley, R. C. & Hendrickson, T. Semianalytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 112, 6127\u20136129 (1990).","journal-title":"J. Am. Chem. Soc."},{"key":"60085_CR36","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/jcc.540110405","volume":"11","author":"F Mohamadi","year":"1990","unstructured":"Mohamadi, F. et al. Macromodel\u2014an integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J. Comput. Chem. 11, 440\u2013467 (1990).","journal-title":"J. Comput. Chem."},{"key":"60085_CR37","unstructured":"MacroModel, S. M. D. & Suite Release 2025-3, Schr\u00f6dinger (LLC, 2025)."},{"key":"60085_CR38","unstructured":"Epik, S. M. D. & Suite Release 2025-3, Schr\u00f6dinger (LLC, 2025)."},{"key":"60085_CR39","unstructured":"Frisch, G. W. et al. J. B. Foresman, J. V. Ortiz, J. Cioslowski, and D. J. Fox, Gaussian, Inc., Wallingford CT, (2009)."},{"key":"60085_CR40","unstructured":"Glide, S. M. D. & Suite Release 2025-3, Schr\u00f6dinger (LLC, 2025)."},{"key":"60085_CR41","unstructured":"Bell, J. A. et al. Chapter 18.10. PrimeX and the Schro\u00a8 dinger computational chemistry suite of programs."},{"key":"60085_CR42","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1021\/acs.jcim.6b00088","volume":"56","author":"P Gramatica","year":"2016","unstructured":"Gramatica, P. & Sangion, A. A Historical Excursus on the Statistical Validation Parameters for QSAR Models: A Clarification Concerning Metrics and Terminology. J. Chem. Inf. Model. 56, 1127\u20131131 (2016).","journal-title":"J. Chem. Inf. Model."},{"key":"60085_CR43","volume-title":"Exploring QSAR: Hydrophobic, Electronic, and Steric Constants \/ Corwin Hansch, Albert Leo, David Hoekman","author":"C Hansch","year":"1995","unstructured":"Hansch, C., Leo, A. & Hoekman, D. H. Exploring QSAR: Hydrophobic, Electronic, and Steric Constants \/ Corwin Hansch, Albert Leo, David Hoekman (American Chemical Society, 1995)."},{"key":"60085_CR44","volume-title":"Molecular Modelling: Principles and Applications","author":"AR Leach","year":"2001","unstructured":"Leach, A. R. Molecular Modelling: Principles and Applications 2nd ed. (Prentice Hall, 2001).","edition":"2nd ed."},{"key":"60085_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0169-7439(02)00090-4","volume":"65","author":"J Riu","year":"2003","unstructured":"Riu, J. & Bro, R. Jack-knife technique for outlier detection and estimation of standard errors in PARAFAC models. Chemometr. Intell. Lab. Syst. 65, 35\u201349 (2003).","journal-title":"Chemometr. Intell. Lab. Syst."},{"issue":"1","key":"60085_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13321-020-00466-z","volume":"12","author":"FI Sald\u00edvar-Gonz\u00e1lez","year":"2020","unstructured":"Sald\u00edvar-Gonz\u00e1lez, F. I., Huerta-Garc\u00eda, C. S. & Medina-Franco, J. L. Chemoinformatics-based enumeration of chemical libraries: A tutorial. J. Cheminform. 1264. (2020).","journal-title":"J. Cheminform."},{"key":"60085_CR47","unstructured":"Maestro, S. M. D. & Suite Release 2025-3, Schr\u00f6dinger (LLC, 2025)."},{"key":"60085_CR48","unstructured":"LigPrep, S. M. D. & Suite Release 2025-3, Schr\u00f6dinger (LLC, 2025)."},{"key":"60085_CR49","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner, R. A. et al. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. J. Med. Chem. 47, 1739\u20131749 (2004).","journal-title":"J. Med. Chem."},{"key":"60085_CR50","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren, T. A. et al. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening. J. Med. Chem. 47, 1750\u20131759 (2004).","journal-title":"J. Med. Chem."},{"key":"60085_CR51","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner, R. A. et al. Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein\u2013Ligand Complexes. J. Med. Chem. 49, 6177\u20136196 (2006).","journal-title":"J. Med. Chem."},{"key":"60085_CR52","doi-asserted-by":"publisher","first-page":"7106","DOI":"10.1021\/acs.jctc.1c00810","volume":"17","author":"Y Yang","year":"2021","unstructured":"Yang, Y. et al. Efficient Exploration of Chemical Space with Docking and Deep Learning. J. Chem. Theory Comput. 17, 7106\u20137119 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"60085_CR53","unstructured":"Prime, S. M. D. & Suite Release 2025-3, Schr\u00f6dinger (LLC, 2025)."},{"key":"60085_CR54","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","volume":"320","author":"MP Jacobson","year":"2002","unstructured":"Jacobson, M. P., Friesner, R. A., Xiang, Z. & Honig, B. On the role of the crystal environment in determining protein side-chain conformations. J. Mol. Biol. 320, 597\u2013608 (2002).","journal-title":"J. Mol. Biol."},{"key":"60085_CR55","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1021\/ct500189s","volume":"10","author":"JL Knight","year":"2014","unstructured":"Knight, J. L. et al. Leveraging Data Fusion Strategies in Multireceptor Lead Optimization MM\/GBSA End-Point Methods. J. Chem. Theory Comput. 10, 3207\u20133220 (2014).","journal-title":"J. Chem. Theory Comput."},{"key":"60085_CR56","unstructured":"Desmond Molecular dynamics system and maestro-desmond interoperability Tools & Suite, S. M. D. Release 2025-3, D. E. Shaw Research, Schr\u00f6dinger, New York, NY, (2025)."},{"key":"60085_CR57","doi-asserted-by":"publisher","unstructured":"Bowers, K. J. et al. Association for Computing Machinery, New York, NY, USA,. Scalable algorithms for molecular dynamics simulations on commodity clusters. In Proceedings of the 2006 ACM\/IEEE conference on Supercomputing 84-es. https:\/\/doi.org\/10.1145\/1188455.1188544 (2006).","DOI":"10.1145\/1188455.1188544"},{"key":"60085_CR58","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926\u2013935 (1983).","journal-title":"J. Chem. Phys."},{"key":"60085_CR59","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1080\/00268979600100761","volume":"87","author":"GJ Martyna","year":"1996","unstructured":"Martyna, G. J., Tuckerman, M. E., Tobias, D. J. & Klein, M. L. Explicit reversible integrators for extended systems dynamics. Mol. Phys. 87, 1117\u20131157 (1996).","journal-title":"Mol. Phys."},{"key":"60085_CR60","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1063\/1.463137","volume":"97","author":"M Tuckerman","year":"1992","unstructured":"Tuckerman, M., Berne, B. J. & Martyna, G. J. Reversible multiple time scale molecular dynamics. J. Chem. Phys. 97, 1990\u20132001 (1992).","journal-title":"J. Chem. Phys."},{"key":"60085_CR61","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1063\/1.467468","volume":"101","author":"GJ Martyna","year":"1994","unstructured":"Martyna, G. J., Tobias, D. J. & Klein, M. L. Constant pressure molecular dynamics algorithms. J. Chem. Phys. 101, 4177\u20134189 (1994).","journal-title":"J. Chem. Phys."},{"key":"60085_CR62","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1063\/1.463940","volume":"97","author":"GJ Martyna","year":"1992","unstructured":"Martyna, G. J., Klein, M. L. & Tuckerman, M. Nos\u00e9\u2013Hoover chains: The canonical ensemble via continuous dynamics. J. Chem. Phys. 97, 2635\u20132643 (1992).","journal-title":"J. Chem. Phys."},{"key":"60085_CR63","doi-asserted-by":"publisher","first-page":"40244","DOI":"10.1039\/D0RA08304F","volume":"10","author":"V Frecer","year":"2020","unstructured":"Frecer, V. & Miertus, S. Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease. RSC Adv. 10, 40244\u201340263 (2020).","journal-title":"RSC Adv."},{"key":"60085_CR64","unstructured":"Jaguar, S. M. D. & Suite Release 2025-3, Schr\u00f6dinger (LLC, 2025)."},{"key":"60085_CR65","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/qua.24481","volume":"113","author":"AD Bochevarov","year":"2013","unstructured":"Bochevarov, A. D. et al. Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences. Int. J. Quantum Chem. 113, 2110\u20132142 (2013).","journal-title":"Int. J. Quantum Chem."},{"key":"60085_CR66","unstructured":"QSite, S. M. D. & Suite Release 2025-3, Schr\u00f6dinger (LLC, 2025)."},{"key":"60085_CR67","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/(SICI)1096-987X(19991115)20:14<1468::AID-JCC2>3.0.CO;2-0","volume":"20","author":"DM Philipp","year":"1999","unstructured":"Philipp, D. M. & Friesner, R. A. Mixed ab initio QM\/MM modeling using frozen orbitals and tests with alanine dipeptide and tetrapeptide. J. Comput. Chem. 20, 1468\u20131494 (1999).","journal-title":"J. Comput. Chem."},{"key":"60085_CR68","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/1096-987X(200012)21:16<1442::AID-JCC3>3.0.CO;2-O","volume":"21","author":"RB Murphy","year":"2000","unstructured":"Murphy, R. B., Philipp, D. M. & Friesner, R. A. A mixed quantum mechanics\/molecular mechanics (QM\/MM) method for large-scale modeling of chemistry in protein environments. J. Comput. Chem. 21, 1442\u20131457 (2000).","journal-title":"J. Comput. Chem."},{"key":"60085_CR69","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jcc.540090407","volume":"9","author":"MK Gilson","year":"1988","unstructured":"Gilson, M. K., Sharp, K. A. & Honig, B. H. Calculating the electrostatic potential of molecules in solution: Method and error assessment. J. Comput. Chem. 9, 327\u2013335 (1988).","journal-title":"J. Comput. Chem."},{"key":"60085_CR70","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/prot.340040104","volume":"4","author":"MK Gilson","year":"1988","unstructured":"Gilson, M. K. & Honig, B. Calculation of the total electrostatic energy of a macromolecular system: Solvation energies, binding energies, and conformational analysis. Proteins Struct. Funct. Bioinform. 4, 7\u201318 (1988).","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"60085_CR71","unstructured":"QikProp, S. M. D. & Suite Release 2025-3, Schr\u00f6dinger (LLC, 2025)."},{"key":"60085_CR72","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0960-894X(00)00172-4","volume":"10","author":"WL Jorgensen","year":"2000","unstructured":"Jorgensen, W. L. & Duffy, E. M. Prediction of drug solubility from Monte Carlo simulations. Bioorg. Med. Chem. Lett. 10, 1155\u20131158 (2000).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"60085_CR73","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1021\/ja993663t","volume":"122","author":"EM Duffy","year":"2000","unstructured":"Duffy, E. M. & Jorgensen, W. L. Prediction of properties from simulations: Free energies of solvation in hexadecane, octanol, and water. J. Am. Chem. Soc. 122, 2878\u20132888 (2000).","journal-title":"J. Am. Chem. Soc."},{"key":"60085_CR74","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0169-409X(02)00008-X","volume":"54","author":"WL Jorgensen","year":"2002","unstructured":"Jorgensen, W. L. & Duffy, E. M. Prediction of drug solubility from structure. Adv. Drug Deliv. Rev. 54, 355\u2013366 (2002).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"60085_CR75","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.1073\/pnas.0510851103","volume":"103","author":"K Ratia","year":"2006","unstructured":"Ratia, K. et al. Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzyme. Proc. Natl. Acad. Sci. U. S. A. 103, 5717\u20135722 (2006).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"60085_CR76","doi-asserted-by":"publisher","first-page":"8408","DOI":"10.1021\/acs.jmedchem.0c00754","volume":"63","author":"P Ertl","year":"2020","unstructured":"Ertl, P., Altmann, E. & McKenna, J. M. The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time. J. Med. Chem. 63, 8408\u20138418 (2020).","journal-title":"J. Med. Chem."},{"key":"60085_CR77","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton, A. et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 40, D1100\u2013D1107 (2012).","journal-title":"Nucleic Acids Res."},{"key":"60085_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106774","volume":"191","author":"R Roskoski","year":"2023","unstructured":"Roskoski, R. Rule of five violations among the FDA-approved small molecule protein kinase inhibitors. Pharmacol. Res. 191, 106774 (2023).","journal-title":"Pharmacol. Res."},{"key":"60085_CR79","doi-asserted-by":"publisher","DOI":"10.36468\/pharmaceutical-sciences.1144","author":"RC Vedarathinam","year":"2023","unstructured":"Vedarathinam, R. C., Rajkumar, Y., Prem, P., Vetriselvan, P. & Kurian, G. A. High susceptibility of statin-treated heart to ischemia-reperfusion: Combinatorial effects of resveratrol alpha-lipoic acid and coenzyme Q10. IJPS https:\/\/doi.org\/10.36468\/pharmaceutical-sciences.1144 (2023).","journal-title":"IJPS"},{"key":"60085_CR80","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7326\/0003-4819-84-2-181","volume":"84","author":"JR Mitchell","year":"1976","unstructured":"Mitchell, J. R. et al. Isoniazid liver injury: Clinical spectrum, pathology, and probable pathogenesis. Ann. Intern. Med. 84, 181\u2013192 (1976).","journal-title":"Ann. Intern. Med."},{"key":"60085_CR81","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1107\/S0021889890013486","volume":"24","author":"RJ Cernik","year":"1991","unstructured":"Cernik, R. J. et al. The structure of cimetidine (C10 H16 N6 S) solved from synchrotron-radiation X-ray powder diffraction data. J. Appl. Crystallogr. 24, 222\u2013226 (1991).","journal-title":"J. Appl. Crystallogr."},{"key":"60085_CR82","doi-asserted-by":"publisher","first-page":"20399","DOI":"10.1021\/acs.jmedchem.4c01872","volume":"67","author":"B Tan","year":"2024","unstructured":"Tan, B. et al. Structure-Based Design of Covalent SARS-CoV-2 Papain-like Protease Inhibitors. J. Med. Chem. 67, 20399\u201320420 (2024).","journal-title":"J. Med. Chem."},{"key":"60085_CR83","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0022-3565(25)25600-2","volume":"126","author":"H McKennis","year":"1959","unstructured":"McKennis, H., Yard, A. S., Weatherby, J. H. & Hagy, J. A. Acetylation of hydrazine and the formation of 1,2-diacetylhydrazine in vivo. J. Pharmacol. Exp. Ther. 126, 109\u2013116 (1959).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"60085_CR84","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev.ento.43.1.545","volume":"43","author":"TS Dhadialla","year":"1998","unstructured":"Dhadialla, T. S., Carlson, G. R. & Le, D. P. New insecticides with ecdysteroidal and juvenile hormone activity. Annu. Rev. Entomol. 43, 545\u2013569 (1998).","journal-title":"Annu. Rev. Entomol."},{"key":"60085_CR85","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/ardp.19873200708","volume":"320","author":"J Bonjean","year":"1987","unstructured":"Bonjean, J. & Schunack, W. H2 -Antihistaminika, 36. Mitt. Isolamtidin und Analoge. Arch. Pharm. 320, 608\u2013616 (1987).","journal-title":"Arch. Pharm."},{"key":"60085_CR86","doi-asserted-by":"publisher","unstructured":"Baldwin, J. Rules for Ring Closure. In Ciba Foundation Symposium 53 - Further Perspectives in Organic Chemistry 85\u2013106 (John Wiley & Sons, Ltd, 1978). https:\/\/doi.org\/10.1002\/9780470720349.ch7.","DOI":"10.1002\/9780470720349.ch7"},{"key":"60085_CR87","first-page":"168","volume":"5","author":"BK Sinha","year":"2014","unstructured":"Sinha, B. K. & Mason, R. P. Biotransformation of hydrazine dervatives in the mechanism of toxicity. J. Drug Metab. Toxicol. 5, 168 (2014).","journal-title":"J. Drug Metab. Toxicol."},{"key":"60085_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.comtox.2021.100169","volume":"18","author":"H Wang","year":"2021","unstructured":"Wang, H., Jia, Y., Jing, G. & Wu, X. A novel toxicity prediction model for hydrazine compounds based on 1D\u20133D molecular descriptors. Computational Toxicology 18, 100169 (2021).","journal-title":"Computational Toxicology"},{"key":"60085_CR89","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00102-15","volume":"29","author":"E De Clercq","year":"2016","unstructured":"De Clercq, E. & Li, G. Approved Antiviral Drugs over the Past 50 Years. Clin. Microbiol. Rev. 29, 695\u2013747 (2016).","journal-title":"Clin. Microbiol. Rev."},{"key":"60085_CR90","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0140-6736(24)01307-2","volume":"404","author":"Y Gao","year":"2024","unstructured":"Gao, Y. et al. Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials. Lancet 404, 753\u2013763 (2024).","journal-title":"Lancet"},{"key":"60085_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118105","volume":"300","author":"MG Nizi","year":"2025","unstructured":"Nizi, M. G., Massari, S., Tabarrini, O. & Manfroni, G. A medicinal chemistry overview of direct-acting antivirals approved in 2013\u20132024 by US FDA. European Journal of Medicinal Chemistry 300, 118105 (2025).","journal-title":"European Journal of Medicinal Chemistry"},{"key":"60085_CR92","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3390\/pathogens11091008","volume":"11","author":"J Tan","year":"2022","unstructured":"Tan, J. et al. Association between Mutations in Papain-like Protease (PLpro) of SARS-CoV-2 with COVID-19 Clinical Outcomes. Pathogens 11, 1008 (2022).","journal-title":"Pathogens"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60085-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:04:10Z","timestamp":1790989450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60085-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60085"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60085-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30474"}}